ATE183644T1 - Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden - Google Patents

Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden

Info

Publication number
ATE183644T1
ATE183644T1 AT96924834T AT96924834T ATE183644T1 AT E183644 T1 ATE183644 T1 AT E183644T1 AT 96924834 T AT96924834 T AT 96924834T AT 96924834 T AT96924834 T AT 96924834T AT E183644 T1 ATE183644 T1 AT E183644T1
Authority
AT
Austria
Prior art keywords
therapy
prevention
lercanidipine
atherosclerotic
dihydropyridine derivatives
Prior art date
Application number
AT96924834T
Other languages
English (en)
Inventor
Abraham Sartani
Amedeo Leonardi
Rodolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Application granted granted Critical
Publication of ATE183644T1 publication Critical patent/ATE183644T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT96924834T 1995-07-14 1996-06-28 Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden ATE183644T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI951513A IT1275532B (it) 1995-07-14 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa

Publications (1)

Publication Number Publication Date
ATE183644T1 true ATE183644T1 (de) 1999-09-15

Family

ID=11371972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924834T ATE183644T1 (de) 1995-07-14 1996-06-28 Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden

Country Status (19)

Country Link
EP (1) EP0839036B1 (de)
JP (1) JPH11509214A (de)
KR (1) KR19990028741A (de)
CN (1) CN1190345A (de)
AT (1) ATE183644T1 (de)
AU (1) AU690471B2 (de)
CA (1) CA2219501A1 (de)
CZ (1) CZ11698A3 (de)
DE (1) DE69603968T2 (de)
DK (1) DK0839036T3 (de)
ES (1) ES2138359T3 (de)
GR (1) GR3031096T3 (de)
HU (1) HUP9802736A3 (de)
IL (1) IL122302A (de)
IT (1) IT1275532B (de)
NO (1) NO980171L (de)
SK (1) SK4198A3 (de)
WO (1) WO1997003669A1 (de)
ZA (1) ZA965924B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
EP2585051B2 (de) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmazeutische orale dosierformen mit lercandipin und enalapril und ihren pharmazeutisch akzeptablen salzen
KR101786857B1 (ko) 2010-10-12 2017-10-18 치에시 파마슈티시 에스.피.아. 항미생물제를 함유하는 클레비디핀 에멀젼 제제
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
SI2654729T1 (sl) 2010-12-24 2016-08-31 Krka, D.D., Novo Mesto Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
AU6516496A (en) 1997-02-18
ES2138359T3 (es) 2000-01-01
HUP9802736A2 (hu) 1999-03-29
ITMI951513A0 (it) 1995-07-14
HUP9802736A3 (en) 2000-03-28
AU690471B2 (en) 1998-04-23
JPH11509214A (ja) 1999-08-17
KR19990028741A (ko) 1999-04-15
DE69603968T2 (de) 2000-04-06
CZ11698A3 (cs) 1998-06-17
EP0839036A1 (de) 1998-05-06
ITMI951513A1 (it) 1997-01-14
EP0839036B1 (de) 1999-08-25
IT1275532B (it) 1997-08-07
NO980171D0 (no) 1998-01-14
CN1190345A (zh) 1998-08-12
WO1997003669A1 (en) 1997-02-06
IL122302A0 (en) 1998-04-05
GR3031096T3 (en) 1999-12-31
CA2219501A1 (en) 1997-02-06
ZA965924B (en) 1997-01-30
SK4198A3 (en) 1998-05-06
IL122302A (en) 2000-08-13
DE69603968D1 (de) 1999-09-30
DK0839036T3 (da) 2000-01-24
NO980171L (no) 1998-01-14

Similar Documents

Publication Publication Date Title
AR017639A1 (es) Procedimiento de la alquilacion directa en una etapa, en las posiciones 7 y 10 simultaneamente de las dos funciones hidroxilos de la 10-desacetilbacatina o de los derivados de esta ultima esterificados en la posicion 13.
ATE188469T1 (de) Alkoxy-4(1h)-pyridon-derivative, verfahren zu deren herstellung und deren verwendung als arzneimittel
MC2077A1 (fr) Derives benzoiques et phenylacetiques,procedes pour leur preparation et compositions pharmaceutiques en contenant
FI942076A (fi) Sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkaaineina
IS4536A (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
BR9509135A (pt) Processo para inibição da atividade do fator de tecido para inibição de depósito de plaquetas para inibição da restenose vascular e para tratamento de oclusão aguda de uma artéria coronária
EE9700153A (et) Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
DE69526120D1 (de) Verwendung von nebivolol als anti-atherogenisches mittel
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE183644T1 (de) Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden
PT91863A (pt) Processo de preparacao de uma preparacao farmaceutica a base de gama-interferao
AU6914296A (en) Left coronary artery catheter
DK0441279T3 (da) Bilobalid-phospholipid-komplekser, deres anvendelse og sammensætninger, der indeholder dem
ATA900894A (de) Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
FR2753449B1 (fr) Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
ZA9610722B (en) Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
DE69019019D1 (de) 2,2,4-trisubstituierte tetrahydropyranische Ester und organoleptische Verwendung davon.
AU6048396A (en) Use of brefeldin a and derivatives thereof in the treatment of hyperplasia and related disorders
TW372962B (en) Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient
NO974267D0 (no) Aminotetralinderivat for behandling av kardiovaskulære sykdommer
HUP9601526A3 (en) Peptidyl-arginin-aldehyde derivatives of anticoagulant activity and pharmaceutical compositions containing them
DE59200566D1 (de) Aryl-Chinolyl-substituierte 1,4-Dihydropyridin-dicarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.
FR2725449B1 (fr) Derives de polyazacycloalcanes, leurs complexes metalliques et produits pharmaceutiques incorporant ces complexes
HUP9601527A3 (en) Peptid-aldehyde derivatives of anticoagulant activity and pharmaceutical compositions containing them
ATE157670T1 (de) Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee